232 related articles for article (PubMed ID: 31133717)
1. Upregulation of the NLRC4 inflammasome contributes to poor prognosis in glioma patients.
Lim J; Kim MJ; Park Y; Ahn JW; Hwang SJ; Moon JS; Cho KG; Kwack K
Sci Rep; 2019 May; 9(1):7895. PubMed ID: 31133717
[TBL] [Abstract][Full Text] [Related]
2. Non-canonical NLRC4 inflammasomes in astrocytes contribute to glioma malignancy.
Sim J; Ahn JW; Park J; Kim YJ; Jeong JY; Lee JM; Cho K; Ahn HJ; Sung KS; Moon JS; Moon JH; Lim J
Inflamm Res; 2023 Apr; 72(4):813-827. PubMed ID: 36899084
[TBL] [Abstract][Full Text] [Related]
3. Association of Tim-3/Gal-9 Axis with NLRC4 Inflammasome in Glioma Malignancy: Tim-3/Gal-9 Induce the NLRC4 Inflammasome.
Sim J; Park J; Kim S; Hwang S; Sung K; Lee JE; Yang S; Cho K; Lee S; Moon JS; Ahn J; Lim J
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216164
[TBL] [Abstract][Full Text] [Related]
4. SP1 transcriptionally activates NLRP6 inflammasome and induces immune evasion and radioresistance in glioma cells.
Yu Y; Cao F; Xiong Y; Zhou H
Int Immunopharmacol; 2021 Sep; 98():107858. PubMed ID: 34147913
[TBL] [Abstract][Full Text] [Related]
5. Key component of inflammasome, NLRC4, was identified in the lesional epidermis of psoriatic patients.
Hiruma J; Harada K; Motoyama A; Okubo Y; Maeda T; Yamamoto M; Miyai M; Hibino T; Tsuboi R
J Dermatol; 2018 Aug; 45(8):971-977. PubMed ID: 29797527
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Implications of the Complement Protein C1q in Gliomas.
Mangogna A; Belmonte B; Agostinis C; Zacchi P; Iacopino DG; Martorana A; Rodolico V; Bonazza D; Zanconati F; Kishore U; Bulla R
Front Immunol; 2019; 10():2366. PubMed ID: 31649675
[TBL] [Abstract][Full Text] [Related]
7. ARL3 is downregulated and acts as a prognostic biomarker in glioma.
Wang Y; Zhao W; Liu X; Guan G; Zhuang M
J Transl Med; 2019 Jun; 17(1):210. PubMed ID: 31234870
[TBL] [Abstract][Full Text] [Related]
8.
Qu S; Liu J; Wang H
Front Immunol; 2021; 12():648416. PubMed ID: 33889156
[TBL] [Abstract][Full Text] [Related]
9. Interferon regulatory factor transcript levels correlate with clinical outcomes in human glioma.
Lei J; Zhou MH; Zhang FC; Wu K; Liu SW; Niu HQ
Aging (Albany NY); 2021 Apr; 13(8):12086-12098. PubMed ID: 33902005
[TBL] [Abstract][Full Text] [Related]
10. Integrative analysis regarding the correlation between GAS2 family genes and human glioma prognosis.
Zhao C; Zhang N; Cui X; Zhang X; Ren Y; Su C; He J; Zhang W; Sun X; Yang J; Gao X
Cancer Med; 2021 Apr; 10(8):2826-2839. PubMed ID: 33713047
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive exploration of tumor mutational burden and immune infiltration in diffuse glioma.
Kang K; Xie F; Wu Y; Wang Z; Wang L; Long J; Lian X; Zhang F
Int Immunopharmacol; 2021 Jul; 96():107610. PubMed ID: 33848908
[TBL] [Abstract][Full Text] [Related]
12. Circadian Regulation Patterns With Distinct Immune Landscapes in Gliomas Aid in the Development of a Risk Model to Predict Prognosis and Therapeutic Response.
Tian R; Li Y; Shu M
Front Immunol; 2021; 12():797450. PubMed ID: 35069579
[TBL] [Abstract][Full Text] [Related]
13. Cytokine Secretion and Pyroptosis of Thyroid Follicular Cells Mediated by Enhanced NLRP3, NLRP1, NLRC4, and AIM2 Inflammasomes Are Associated With Autoimmune Thyroiditis.
Guo Q; Wu Y; Hou Y; Liu Y; Liu T; Zhang H; Fan C; Guan H; Li Y; Shan Z; Teng W
Front Immunol; 2018; 9():1197. PubMed ID: 29915579
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of NLRC4, NLRP1, and NLRP3, as Components of Inflammasomes, in Chronic Hepatitis B Virus-Infected Patients.
Askari A; Nosratabadi R; Khaleghinia M; Zainodini N; Kennedy D; Shabani Z; Kazemi Arababadi M
Viral Immunol; 2016 Nov; 29(9):496-501. PubMed ID: 27750030
[TBL] [Abstract][Full Text] [Related]
15. Aberrant expression of interleukin-1β and inflammasome activation in human malignant gliomas.
Tarassishin L; Casper D; Lee SC
PLoS One; 2014; 9(7):e103432. PubMed ID: 25054228
[TBL] [Abstract][Full Text] [Related]
16. Immune Cytolytic Activity Is Associated With Genetic and Clinical Properties of Glioma.
Wang ZL; Wang Z; Li GZ; Wang QW; Bao ZS; Zhang CB; Jiang T
Front Immunol; 2019; 10():1756. PubMed ID: 31428092
[No Abstract] [Full Text] [Related]
17. Investigation of Genetic Determinants of Glioma Immune Phenotype by Integrative Immunogenomic Scale Analysis.
Zhao B; Wang Y; Wang Y; Dai C; Wang Y; Ma W
Front Immunol; 2021; 12():557994. PubMed ID: 34220791
[TBL] [Abstract][Full Text] [Related]
18. A role for the NLRC4 inflammasome in premature rupture of membrane.
Zhu J; Ma C; Zhu L; Li J; Peng F; Huang L; Luan X
PLoS One; 2020; 15(8):e0237847. PubMed ID: 32833985
[TBL] [Abstract][Full Text] [Related]
19. Involvement of the NLRC4-Inflammasome in Diabetic Nephropathy.
Yuan F; Kolb R; Pandey G; Li W; Sun L; Liu F; Sutterwala FS; Liu Y; Zhang W
PLoS One; 2016; 11(10):e0164135. PubMed ID: 27706238
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of plasma miR-124 expression is a predictive biomarker for prognosis of glioma.
Wang LQ; Sun W; Wang Y; Li D; Hu AM
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):271-276. PubMed ID: 30657585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
